Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 195-204

  Tsukamoto, Hiroki ^a,b   Fukudome, Kenji ^a   Takao, Shoko ^a   Tsuneyoshi, Naoko ^a   Ohta, Shoichiro ^a   Nagai, Yoshinori ^c   Ihara, Hideyuki ^b   Miyake, Kensuke ^d   Ikeda, Yoshitaka ^b   Kimoto, Masao ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BAGG ALBINO MOUSE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENETIC TRANSFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 4 GENE; UPREGULATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; HEK293 CELLS; HUMANS; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; POINT MUTATION; RATS; RATS, WISTAR; TOLL-LIKE RECEPTOR 4;

EID: 84871838135     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201047     Document Type: Article

References (43)

1. Gray, D., M. Gray, and T. Barr. 2007. Innate responses of B cells. Eur. J. Immunol. 37: 3304-3310.
2. Lanzavecchia, A., and F. Sallusto. 2007. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr. Opin. Immunol. 19: 268-274. (Pubitemid 46687008)
3. Peng, S. L. 2005. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17: 230-236. (Pubitemid 40692656)
4. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752. (Pubitemid 29314747)
5. Ogata, H., I. Su, K. Miyake, Y. Nagai, S. Akashi, I. Mecklenbräuker, K. Rajewsky, M. Kimoto, and A. Tarakhovsky. 2000. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192: 23-29. (Pubitemid 30470803)
6. Nagai, Y., S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto, and K. Miyake. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3: 667-672. (Pubitemid 34752476)
7. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
8. Park, B. S., D. H. Song, H. M. Kim, B. S. Choi, H. Lee, and J. O. Lee. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
9. Takahashi, K., T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, et al. 2007. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J. Exp. Med. 204: 2963-2976. (Pubitemid 350179564)
10. Yang, Y., B. Liu, J. Dai, P. K. Srivastava, D. J. Zammit, L. Lefrançois, and Z. Li. 2007. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26: 215-226. (Pubitemid 46329432)
11. Wakabayashi, Y., M. Kobayashi, S. Akashi-Takamura, N. Tanimura, K. Konno, K. Takahashi, T. Ishii, T. Mizutani, H. Iba, T. Kouro, et al. 2006. A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J. Immunol. 177: 1772-1779. (Pubitemid 44092514)
12. Ohnishi, T., M. Muroi, and K. Tanamoto. 2003. MD-2 is necessary for the tolllike receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 10: 405-410. (Pubitemid 36592967)
13. Visintin, A., K. A. Halmen, N. Khan, B. G. Monks, D. T. Golenbock, and E. Lien. 2006. MD-2 expression is not required for cell surface targeting of Tolllike receptor 4 (TLR4). J. Leukoc. Biol. 80: 1584-1592. (Pubitemid 44904997)
14. Miyake, K., Y. Yamashita, M. Ogata, T. Sudo, and M. Kimoto. 1995. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154: 3333-3340.
15. Nagai, Y., R. Shimazu, H. Ogata, S. Akashi, K. Sudo, H. Yamasaki, S. Hayashi, Y. Iwakura, M. Kimoto, and K. Miyake. 2002. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99: 1699-1705. (Pubitemid 34533044)
16. Miyake, K., Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto. 1994. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180: 1217-1224. (Pubitemid 24289595)
17. Harada, H., U. Ohto, and Y. Satow. 2010. Crystal structure of mouse MD-1 with endogenous phospholipid bound in its cavity. J. Mol. Biol. 400: 838-846.
18. Yoon, S. I., M. Hong, G. W. Han, and I. A. Wilson. 2010. Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc. Natl. Acad. Sci. USA 107: 10990-10995.
19. Nagai, Y., T. Kobayashi, Y. Motoi, K. Ishiguro, S. Akashi, S. Saitoh, Y. Kusumoto, T. Kaisho, S. Akira, M. Matsumoto, et al. 2005. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes. J. Immunol. 174: 7043-7049. (Pubitemid 40705669)
20. Blumenthal, A., T. Kobayashi, L. M. Pierini, N. Banaei, J. D. Ernst, K. Miyake, and S. Ehrt. 2009. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe 5: 35-46.
21. Vale, A. M., E. Hayashi, A. Granato, H. W. Schroeder, Jr., M. Bellio, and A. Nobrega. 2010. Genetic control of the B cell response to LPS: opposing effects in peritoneal versus splenic B cell populations. Immunogenetics 62: 41- 48.
22. Rodo, J., L. A. Gonçalves, J. Demengeot, A. Coutinho, and C. Penha-Gonçalves. 2006. MHC class II molecules control murine B cell responsiveness to lipopolysaccharide stimulation. J. Immunol. 177: 4620-4626. (Pubitemid 44469794)
23. Wells, C. A., T. Ravasi, G. J. Faulkner, P. Carninci, Y. Okazaki, Y. Hayashizaki, M. Sweet, B. J.Wainwright, and D. A. Hume. 2003. Genetic control of the innate immune response. BMC Immunol. 4: 5.
24. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
25. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25: 187-191. (Pubitemid 30394990)
26. Bahrun, U., M. Kimoto, H. Tsukamoto, N. Tsuneyoshi, J. Kohara, and K. Fukudome. 2007. Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex. Hybridoma (Larchmt) 26: 393-399.
27. Tsuneyoshi, N., J. Kohara, U. Bahrun, S. Saitoh, S. Akashi, J. F. Gauchat, M. Kimoto, and K. Fukudome. 2006. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Cell. Immunol. 244: 57-64. (Pubitemid 46659717)
28. Tsukamoto, H., K. Fukudome, S. Takao, N. Tsuneyoshi, and M. Kimoto. 2010. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Int. Immunol. 22: 271-280.
29. Tsukamoto, H., K. Fukudome, S. Takao, N. Tsuneyoshi, H. Ihara, Y. Ikeda, and M. Kimoto. 2012. Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs. Int. Immunol. 24: 495-506.
30. Ohta, S., U. Bahrun, R. Shimazu, H. Matsushita, K. Fukudome, and M. Kimoto. 2006. Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex. Clin. Vaccine Immunol. 13: 1131-1136. (Pubitemid 44622541)
31. Smirnova, I., A. Poltorak, E. K. Chan, C. McBride, and B. Beutler. 2000. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 1:RESEARCH002.
32. Liu, B., Y. Yang, J. Dai, R. Medzhitov, M. A. Freudenberg, P. L. Zhang, and Z. Li. 2006. TLR4 up-regulation at protein or gene level is pathogenic for lupuslike autoimmune disease. J. Immunol. 177: 6880-6888. (Pubitemid 44715053)
33. Kalis, C., B. Kanzler, A. Lembo, A. Poltorak, C. Galanos, and M. A. Freudenberg. 2003. Toll-like receptor 4 expression levels determine the degree of LPSsusceptibility in mice. Eur. J. Immunol. 33: 798-805. (Pubitemid 36367683)
34. Kim, H. M., B. S. Park, J. I. Kim, S. E. Kim, J. Lee, S. C. Oh, P. Enkhbayar, N. Matsushima, H. Lee, O. J. Yoo, and J. O. Lee. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906- 917.
35. Kiyokawa, T., S. Akashi-Takamura, T. Shibata, F. Matsumoto, C. Nishitani, Y. Kuroki, Y. Seto, and K. Miyake. 2008. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors. Int. Immunol. 20: 1407-1415.
36. Shibata, T., Y. Motoi, N. Tanimura, N. Yamakawa, S. Akashi-Takamura, and K. Miyake. 2011. Intracellular TLR4/MD-2 in macrophages senses Gramnegative bacteria and induces a unique set of LPS-dependent genes. Int. Immunol. 23: 503-510.
37. Liu, T., T. Matsuguchi, N. Tsuboi, T. Yajima, and Y. Yoshikai. 2002. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 70: 6638-6645. (Pubitemid 35387892)
38. Kuroda, E., and U. Yamashita. 2003. Mechanisms of enhanced macrophagemediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J. Immunol. 170: 757-764. (Pubitemid 36070526)
39. De Maio, A., M. B. Torres, and R. H. Reeves. 2005. Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 23: 11-17. (Pubitemid 40089520)
40. Matesic, L. E., A. De Maio, and R. H. Reeves. 1999. Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains. Genomics 62: 34-41.
41. Yang, I. V., S. Alper, B. Lackford, H. Rutledge, L. A. Warg, L. H. Burch, and D. A. Schwartz. 2011. Novel regulators of the systemic response to lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 45: 393-402.
42. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871. (Pubitemid 16246587)
43. Quintana, F. J., A. Solomon, I. R. Cohen, and G. Nussbaum. 2008. Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS ONE 3: e3509.